Raul Collazo
Chief Tech/Sci/R&D Officer chez CONNECT BIOPHARMA HOLDINGS LIMITED
Profil
Raul Collazo is currently the Vice President-Medical & Scientific Affairs at Biotheranostics, Inc. and the Vice President & Global Head-Medical Affairs at Connect Biopharma Holdings Ltd.
He holds a doctorate degree from the University of Oregon.
Postes actifs de Raul Collazo
| Sociétés | Poste | Début |
|---|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 01/11/2021 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | - |
Formation de Raul Collazo
| University of Oregon | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CONNECT BIOPHARMA HOLDINGS LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Biotheranostics, Inc. develops and provides diagnostic, prognostic and predictive tests that support physicians in the treatment of cancer patients. It has commercialized two proprietary, highly differentiated products focused on early stage breast cancer and all metastatic cancers, Breast Cancer Index (BCI) and CancerTYPE ID (CTID). The company was founded by Thomas M. Baer in 2008 and is headquartered in San Diego, CA. | Health Services |
